CHA
CVAC

Carmichael Hill & Associates’s CureVac CVAC Stock Holding History

Carmichael Hill & Associates’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$1K – 776
2021
Q1 		$1K Buy
15
+3
+25% +$291 ﹤0.01% 734
2020
Q4 		$1K Sell
12
-28
-70% -$2.14K ﹤0.01% 706
2020
Q3 		$2K Buy
+40
New +$2.23K ﹤0.01% 654

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carmichael Hill & Associates's CVAC Position: Q2 2021 in Review

Carmichael Hill & Associates sold out of CureVac (CVAC) in Q2 2021, closing a stake of 15 shares — an estimated $1K sold.

Carmichael Hill & Associates first reported a position in CVAC in Q3 2020 and held it in 3 quarters. The position peaked at $2K in Q3 2020. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

  • Carmichael Hill & Associates reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
  • Carmichael Hill & Associates sold 15 CureVac shares in Q2 2021, an estimated $1K.
  • Carmichael Hill & Associates first reported a position in CureVac in Q3 2020 and held it in 3 quarters.
  • Carmichael Hill & Associates's CureVac position peaked at $2K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Carmichael Hill & Associates's 13F filing for Q2 2021, filed 3 Aug 2021.